Vantage Investment Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
BG
Vantage Investment Advisors's AGN Position: Q3 2018 in Review
Vantage Investment Advisors held its Allergan plc (AGN) position steady in Q3 2018 at 40 shares worth $8K. The position accounts for ﹤0.01% of the portfolio, ranked #585.
Vantage Investment Advisors first reported a position in AGN in Q1 2016 and has held it in 11 quarters since. The position peaked at $228K in Q2 2016. 1,067 funds tracked by Wall St. Rank hold AGN as of Q3 2018.
- Vantage Investment Advisors held 40 shares of Allergan plc worth $8K as of Q3 2018.
- Vantage Investment Advisors left its Allergan plc share count unchanged in Q3 2018.
- Allergan plc made up ﹤0.01% of Vantage Investment Advisors's portfolio in Q3 2018, its #585 holding.
- Vantage Investment Advisors first reported a position in Allergan plc in Q1 2016 and has held it in 11 quarters since.
- Vantage Investment Advisors's Allergan plc position peaked at $228K in Q2 2016.
- 1,067 funds tracked by Wall St. Rank held Allergan plc as of Q3 2018.
Based on Vantage Investment Advisors's 13F filing for Q3 2018, filed 9 Nov 2018.